Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Can Fite Biopharma Ltd (ADR) Company Profile (NASDAQ:CANF)

Consensus Ratings for Can Fite Biopharma Ltd (ADR) (NASDAQ:CANF) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: $28.00 (797.44% upside)

Analysts' Ratings History for Can Fite Biopharma Ltd (ADR) (NASDAQ:CANF)
Show:
DateFirmActionRatingPrice TargetDetailsShare
12/23/2013Roth CapitalBoost Price Target$28.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 10/20/2012 forward)
Discuss Can Fite Biopharma Ltd (ADR)